AbCellera Biologics Inc.
ABCL
$3.74
$0.102.75%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
5/16/2024
-
Tickeron - Stocks
5/14/2024
-
Zolmax
5/13/2024
-
InvestorPlace
5/12/2024
-
Zolmax
5/10/2024
-
Ticker Report
5/10/2024
-
Zolmax
5/9/2024
-
Tickeron - Stocks
5/8/2024
-
Ticker Report
5/8/2024
-
Fool.com Headlines
5/8/2024
-
GuruFocus
5/8/2024
-
Seeking Alpha: Transcripts
5/8/2024
-
SeekingAlpha
5/8/2024
-
InvestorPlace
5/7/2024
-
Zacks Investment Research
5/7/2024
-
GuruFocus
5/7/2024
-
Business Wire
5/4/2024
-
Ticker Report
5/2/2024
-
Zolmax
5/1/2024
-
Zacks Investment Research
5/1/2024
-
Business Wire
4/30/2024
-
Zacks Investment Research
4/27/2024
-
Tickeron - Stocks
4/27/2024
-
Tickeron - Stocks
4/26/2024
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 20, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604-559-9005
Address
2215 Yukon Street
Vancouver, BC V5Y 0A1
Vancouver, BC V5Y 0A1
Country
Year Founded
Business Description
Sector
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The...
more
